Cargando…
Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers
INTRODUCTION: Although lymph node negative (LN-) breast cancer patients have a good 10-years survival (∼85%), most of them still receive adjuvant therapy, while only some benefit from this. More accurate prognostication of LN- breast cancer patient may reduce over- and under-treatment. Until now pro...
Autores principales: | Jonsdottir, Kristin, Janssen, Susanne R., Da Rosa, Fabiana C., Gudlaugsson, Einar, Skaland, Ivar, Baak, Jan P. A., Janssen, Emiel A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492447/ https://www.ncbi.nlm.nih.gov/pubmed/23144930 http://dx.doi.org/10.1371/journal.pone.0048692 |
Ejemplares similares
-
Prognostic Value of Gene Signatures and Proliferation in Lymph-Node-Negative Breast Cancer
por: Jonsdottir, Kristin, et al.
Publicado: (2014) -
Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients
por: Egeland, Nina Gran, et al.
Publicado: (2019) -
The Prognostic Value of the Proliferation Marker Phosphohistone H3 (PPH3) in Luminal, Basal-Like and Triple Negative Phenotype Invasive Lymph Node-Negative Breast Cancer
por: Skaland, Ivar, et al.
Publicado: (2009) -
LOH at 1p31 (ARHI) and Proliferation in Lymph Node-Negative Breast Cancer
por: Janssen, Emiel A. M., et al.
Publicado: (2009) -
MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers
por: Egeland, Nina Gran, et al.
Publicado: (2020)